2013 Press Releases
2013 |
2012
|
2011
Keyword Search
Date
Title
05/16/13
Depomed To Present At UBS Global Healthcare Conference
05/08/13
Depomed Reports First Quarter 2013 Financial Results
05/01/13
Depomed To Report First Quarter Fiscal Year 2013 Financial Results On Wednesday, May 8, 2013
03/13/13
Depomed To Present At Roth Capital Partners 25th Annual Growth Stock Conference
03/04/13
Trading of Depomed Common Stock Halted
03/04/13
Depomed Provides Update on SEFELSA™ FDA Advisory Committee
02/26/13
Depomed To Present At Cowen and Company Health Care Conference
02/20/13
Depomed Reports Fourth Quarter and Full Year 2012 Financial Results
02/13/13
Depomed To Report Fourth Quarter Fiscal Year 2012 Financial Results On Wednesday, February 20, 2013
02/11/13
Depomed Announces Appointment of Vicente J. Anido, Jr., Ph.D. to Board of Directors, and Retirement of Directors Julian N. Stern and Craig R. Smith, M.D.
DEPO (Common Stock)
Exchange
NASDAQ CM
Price
$5.89
Change (%)
+ 0.10 (1.73%)
Volume
287,378
Market Cap
$332,808,560
Data as of 05/24/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Powered By EDGAR Online, Inc.
print page
email page
contact IR
rss feeds
email alerts
financial tear sheet
Investors
Management
Board of Directors
Corporate Governance
Press Releases
Analyst Coverage
Quarterly Earnings
Webcast and Presentations
Annual Reports
SEC Filings
Fundamentals
Investor FAQ
Stock Information
Home
About Us
Our Products
Our Pipeline
Our Technology
Investors
Careers
Sitemap
Contact Us
A Growing Specialty Pharmaceutical Company